510(k) Report

510(k) · Cleared

Cleared

Nova Lite Anca

K961340510(k) TraditionalCleared Jul 10, 1996107-day reviewClass II21 CFR 866.5660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Inova Diagnostics, Inc. · MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca)

Cleared on Jul 10, 1996 after a 107-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 4 later devices descend from it.

Decided
Jul 10, 1996
Review
107 days
Class
Class II
Product code
MOB
Recalls
None
Predicates
0

4 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 1998: 2 descendants cleared2017: 1 descendant cleared2007: 1 descendant cleared1995200020052010201520202025
  1. This deviceK961340 Nova Lite AncaInova Diagnostics, Inc. · 1996
  2. Descendant · cites it directly · 0 of its ownK161258 NOVA Lite DAPI ANCA Ethanol Kit, NOVA Lite DAPI ANCA Formalin KitInova Diagnostics, Inc. · 2017
  3. Descendant · cites it directly · 0 of its ownK072358 Bioplex Vasculitis KitBio-Rad Laboratories · 2007
  4. Descendant · cites it directly · 0 of its ownK974478 Immuno Concepts Anca Test SystemsImmuno Concepts, Inc. · 1998
  5. Descendant · cites it directly · 0 of its ownK974463 Immuno Concepts Anca Test SystemImmuno Concepts, Inc. · 1998

Most influential descendants

Showing 4 of 4 · See all
  • K161258NOVA Lite DAPI ANCA Ethanol Kit, NOVA Lite DAPI ANCA Formalin KitInova Diagnostics, Inc. · 2017 · cites it directly0descendants
  • K072358Bioplex Vasculitis KitBio-Rad Laboratories · 2007 · cites it directly0descendants
  • K974478Immuno Concepts Anca Test SystemsImmuno Concepts, Inc. · 1998 · cites it directly0descendants
  • K974463Immuno Concepts Anca Test SystemImmuno Concepts, Inc. · 1998 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K961340Nova Lite AncaInova Diagnostics, Inc.1996—
+1K161258NOVA Lite DAPI ANCA Ethanol Kit, NOVA Lite DAPI ANCA Formalin KitInova Diagnostics, Inc.2017—
+1K072358Bioplex Vasculitis KitBio-Rad Laboratories2007—
+1K974478Immuno Concepts Anca Test SystemsImmuno Concepts, Inc.1998—
+1K974463Immuno Concepts Anca Test SystemImmuno Concepts, Inc.1998—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199820
200710
201710
FIG. 1 — Lineage of K961340, 1996–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MOB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MOB device

  1. #1 K261466 Alegria Flash MPO; Alegria Flash PR3; Alegria…score 11.9 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (4)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K161258NOVA Lite DAPI ANCA Ethanol Kit, NOVA Lite DAPI ANCA Formalin KitInova Diagnostics, Inc.20170
K072358Bioplex Vasculitis KitBio-Rad Laboratories20070
K974478Immuno Concepts Anca Test SystemsImmuno Concepts, Inc.19980
K974463Immuno Concepts Anca Test SystemImmuno Concepts, Inc.19980

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K161258 (Inova Diagnostics, Inc., 2017) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MOB devices

MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MOB

1in 2025

2007: 12009: 22010: 62012: 12014: 12017: 12018: 32025: 12026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MOB

221in 2018

2010: 379 days median2018: 221 days median
2007high 379 (2010) · low 221 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MOB

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MOB

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2025

MAUDE reports naming product code MOB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20092—00
2010637900
20110—00
20121—01
20130—00
20141—00
20150—00
20160—00
20171—00
2018322100
20190—00
20200—00
20210—00
20220—00
20230—10
20240—00
20251—00
20261—0—
Cite this page

510(k) Report. “K961340: Nova Lite Anca.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K961340

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026